Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-058891
Filing Date
2024-03-05
Accepted
2024-03-05 10:13:38
Documents
6
Effectiveness Date
2024-03-05

Document Format Files

Seq Description Document Type Size
1 S-8 d801055ds8.htm S-8 33939
2 EX-5.1 d801055dex51.htm EX-5.1 12162
3 EX-23.1 d801055dex231.htm EX-23.1 1498
4 EX-FILING FEES d801055dexfilingfees.htm EX-FILING FEES 20615
5 GRAPHIC g801055dsp007.jpg GRAPHIC 3101
6 GRAPHIC g801055dsp008.jpg GRAPHIC 1984
  Complete submission text file 0001193125-24-058891.txt   76618
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277658 | Film No.: 24718621
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)